Abstract
BRCA1/2 variants are prognostic biomarkers for hereditary breast and/or ovarian cancer (HBOC) syndrome and predictive biomarkers for PARP inhibition. ......
小提示:本篇文献需要登录阅读全文,点击跳转登录